Loading...
GLP-1 receptor agonists in diabetic kidney disease: from the patient-side to the bench-side
Diabetic kidney disease (DKD), one of the most common and severe microvascular complications of diabetes, is the leading cause of chronic kidney disease and end-stage kidney disease worldwide. Since the development of renin-angiotensin system inhibition nearly three decades ago, no new therapeutic a...
Na minha lista:
| Udgivet i: | Am J Physiol Renal Physiol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Physiological Society
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6337002/ https://ncbi.nlm.nih.gov/pubmed/30110568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.00211.2018 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|